Dodge & Cox
- SEC CIK
- 0000200217
- Latest filing
- Aug 13, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 17,324
- Value
- $1.57M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 17,324 | $1.57M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 17,324 | $1.78M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 17,324 | $2.17M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 17,324 | $2.32M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 17,324 | $2.36M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 17,324 | $2.30M | <0.1% | −533−3.0% | Reduced | Holders |
| Q4 2024 | 17,857 | $2.02M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 17,857 | $2.04M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 17,857 | $1.86M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 17,857 | $2.03M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 17,857 | $1.97M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 17,857 | $1.73M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 17,857 | $1.95M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 17,857 | $1.81M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 17,857 | $1.96M | <0.1% | −467−2.5% | Reduced | Holders |
| Q3 2022 | 18,324 | $1.77M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,324 | $1.99M | <0.1% | −100−0.5% | Reduced | Holders |
| Q1 2022 | 18,424 | $2.18M | <0.1% | −124−0.7% | Reduced | Holders |
| Q4 2021 | 18,548 | $2.61M | <0.1% | −699−3.6% | Reduced | Holders |
| Q3 2021 | 19,247 | $2.27M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 19,247 | $2.23M | <0.1% | −500−2.5% | Reduced | Holders |
| Q1 2021 | 19,747 | $2.37M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.